Previous Article | Next Article 
Journal of Clinical Microbiology, April 1998, p. 866-871, Vol. 36, No. 4
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Molecular Identification of Gemella
Species from Three Patients with Endocarditis
Bernard
La Scola and
Didier
Raoult*
Unité des Rickettsies, CNRS UPRESA
6020, Faculté de Médecine, Université de
la Méditerrannée, 13385 Marseille Cedex 05, France
Received 31 July 1997/Returned for modification 10 October
1997/Accepted 30 December 1997
 |
ABSTRACT |
Gemella morbillorum and Gemella haemolysans
are opportunistic pathogens which cause endocarditis and other severe
infections. We report on three patients with endocarditis, one with
endocarditis caused by G. haemolysans and two with
endocarditis caused by G. morbillorum. The paucity of
reports concerning these bacteria is probably related to the
difficulties associated with their identification. For example, one of
the strains reported in this study was originally sent to our
laboratory with a preliminary characterization as a short
"gram-negative" coccobacillus, highlighting the specific problem
associated with Gram staining of these bacteria. The usefulness of 16S
rRNA gene amplification, partial sequencing, and comparison of the
nucleotide sequence to those in databases when standard phenotypic
identification schemes are not helpful is emphasized. We also suggest
that the use of simple tests, such as testing susceptibility to
vancomycin for gram-negative bacteria and colistin for gram-positive
bacteria, could prevent misinterpretation of Gram staining in
gram-variable bacteria such as Gemella spp.
 |
INTRODUCTION |
Gemella morbillorum and
Gemella haemolysans are gram-positive coccal commensal
organisms of the mucous membranes of humans and other warm-blooded
animals. However, as "opportunistic pathogens," gemellae are able
to cause severe localized and generalized infections.
The cases of Gemella infection reported to date have been
predominantly endovascular infections (1, 6, 8-12, 15, 22, 25,
28, 29, 31, 33-35, 39, 40, 43, 45). Among these cases of
Gemella infection, most are endocarditis, usually associated with previous valvular damage and/or poor dental state. Central nervous
system and skeletal infections have also been described (4, 13,
23, 36, 38, 48). In a study of 52 cases of "streptococcal"
endocarditis, gemellae represented 6% of the viridans group
streptococci and 5% of all isolates (17). In our hospital center, gemellae were the cause of 6% of the cases of endocarditis due
to nonstaphylococcal gram-positive cocci, were the cause of 13.3% of
the cases of endocarditis caused by viridans group streptococci, and
represented 2.9% of all bacterial isolates causing 70 cases of
endocarditis diagnosed during a 3-year period (unpublished data).
These bacteria are easily decolorized during Gram staining and
sometimes appear as elongated cells, explaining why they were first
described as Neisseria (46). They may also be
more involved in clinical disease than is presently recognized, because
they can be incorrectly identified as viridans group streptococci or left unidentified (42).
In this paper we report on two patients with G. morbillorum
endocarditis and one patient with G. haemolysans
endocarditis. The identification of one G. morbillorum
strain was achieved with the help of partial 16S rRNA gene sequencing,
since the bacterial isolate appeared to be gram negative. Partial 16S
rRNA gene sequencing was also used as a reference technique to confirm
the identities of a further two strains of Gemella. The
results obtained by electron microscopy and analysis of cell wall fatty
acids are reported, and the previous cases of endocarditis caused by
G. haemolysans and G. morbillorum are reviewed.
 |
CASE REPORTS |
Patient 1.
A 63-year-old man who was a heavy smoker with
chronic obstructive bronchitis and a very poor dental state was
admitted to hospital complaining of intermittent fever, loss of weight,
and anorexia over a 1-month period. He had no history of rheumatic disease, although a moderate heart murmur had been discovered 1 year
previously, and at that time an echocardiogram had yielded moderate
mitral valve regurgitation. On initial examination, the patient had an
increased heart murmur, a temperature of 38.5°C, and a pulse of 100 beats/min. An ejection systolic murmur was heard at the apex of the
heart. Laboratory investigations showed a hemoglobin concentration of
100 g/liter, an erythrocyte sedimentation rate of 97 mm/h, and a
leukocyte count of 8.53 × 109/liter (77%
neutrophils). A transesophageal echocardiogram demonstrated the
presence of vegetation on the mitral valve with moderate mitral valve
regurgitation. Six sets of blood samples for cultures were taken on
admission and the following day, and the blood samples were inoculated
into BACTEC aerobic (NR 6-A*) and anaerobic (NR-7A*) bottles in a
BACTEC NR-860 automated instrument (Becton Dickinson Diagnostic
Instrument Systems, Sparks, Md.). All yielded slowly growing,
gram-positive cocci, subsequently identified as G. haemolysans. A kidney echography, carried out for microscopic
hematuria, yielded a lesion inside of the left kidney which was
compatible with an abscess. The patient's treatment began the day
after his admission, in which treatment with amoxicillin (4 g
intravenously at 6-h intervals) and amikacin (5 mg/kg of body weight
intravenously at 8-h intervals) was begun. His condition improved
rapidly, and after 2 weeks of this regimen, he underwent cardiac
surgery in order to remove the motile vegetation. One week after
surgery antibiotic therapy was discontinued. After 2 years of follow-up he remains well.
Patient 2.
A 74-year-old man with a history of Pott's disease
in infancy, chronic alcoholism, and a poor dental state was admitted to hospital complaining of intermittent fever, sweating, loss of weight,
and basithoracic pain over a 3-month period. He had neither a history
of rheumatic disease nor a previous heart murmur. On initial
examination, the patient had a diastolic heart murmur, a temperature of
38°C, and a pulse of 100 beats/min. Laboratory investigations showed
a hemoglobin concentration of 95 g/liter, an erythrocyte sedimentation
rate of 63 mm/h, and a leukocyte count of 12.8 × 109/liter (87% neutrophils). A transesophageal
echocardiogram demonstrated aortic valve incompetence but failed to
show any vegetation. Six sets of blood samples for culture were taken
on admission and the following day, and the blood samples were
inoculated into BACTEC aerobic (NR 6-A*) and anaerobic (NR-7A*) bottles
in a BACTEC NR-860 automated instrument. All yielded slowly growing,
gram-variable cocci and coccobacilli subsequently identified as
G. morbillorum. The patient's treatment began the day after
his admission and comprised amoxicillin (4 g intravenously at 6-h
intervals) and gentamicin (1 mg/kg intravenously at 8-h intervals).
Although his condition improved rapidly, it was necessary to transfer
him to a cardi-thoracic unit because he was also suffering from
significant aortic valve regurgitation and a dilated left ventricle.
The aortic valve was successfully replaced with a prosthetic device,
and the patient made an uneventful postoperative recovery. Gentamicin was discontinued 1 week later, and amoxicillin was discontinued 3 weeks
later. After 1 year of follow-up he remains well.
Patient 3.
A small, fastidious, gram-negative rod which had
been isolated from the blood of a male patient with infectious
endocarditis by using BACTEC aerobic (NR 6-A*) and anaerobic (NR-7A*)
bottles was sent to our laboratory for identification, because it was thought that it could be a Bartonella sp. The patient was a
farmer and suffered from a bicuspid aortic valve. Clinical symptoms
included intermittent fever and a weight loss of 12 kg over a period of several months. Attempts to amplify citrate synthase and 16S rRNA genes
with specific primers for Bartonella (27) were
unsuccessful. Standard phenotypic characterization methods for
gram-negative rods also failed to provide an identity. The bacterium
was identified as G. morbillorum by 16 rRNA gene sequencing.
 |
MATERIALS AND METHODS |
Phenotypic identification.
Presumptive identification of the
Gemella organisms was achieved through assessment of
colonial morphology, hemolysis on Columbia agar with 5% sheep blood
(BioMerieux, Marcy l'Etoile, France), microscopic appearance after
Gram staining, and the results of biochemical tests (with the API 20 Strep and the API 20A systems according to the manufacturer's
instructions). Growth was also attempted in broth containing 6.5%
NaCl. Susceptibility to vancomycin and colistin was assessed with
30-µg vancomycin and 50-µg colistin disks (Sanofi Diagnostic
Pasteur, Marnes la Coquette, France) and Mueller-Hinton broth with 5%
sheep blood agar (BioMerieux) by the conventional disk diffusion test
method (2). The strain was considered to be susceptible to
vancomycin and to colistin when inhibition zone diameters of
12 and
15 mm, respectively, were observed.
Cellular fatty acids.
Colonies of the three isolates and of
the type strains G. haemolysans ATCC 10379 and G. morbillorum ATCC 27824 were grown on Trypticase soy agar with 5%
sheep blood (Becton Dickinson) at 38°C for 48 h. They were then
saponified, and cell wall fatty acids were extracted and analyzed by
gas chromatography as reported previously (37).
Processing for electron microscopy.
Bacterial cells were
harvested from colonies grown on Columbia agar and for fixation were
suspended in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2)
containing 0.1 M sucrose. The fixed cells were washed overnight with
the same buffer and were then fixed for 1 h at room temperature
with 1% osmium tetroxide in 0.1 M cacodylate buffer. Dehydration was
performed by washing the cells in gradually increased concentrations
(25 to 100%) of ethanol. The cells were then embedded in Epon 812. Thin sections were cut from embedded blocks with an LKB Ultratome III
microtome and were poststained with a saturated solution of
methanol-uranyl acetate and lead citrate in water before examination on
a Jeol JEM 1200 EX electron microscope.
PCR amplification and sequencing of the PCR product.
DNA
extracts, suitable for use as templates in PCRs, were made from 200 µl of a bacterial suspension by using a QIA ampBlood kit (Qiagen,
Hilden, Germany) according to the manufacturer's instructions. All
primer sets used in this study are listed in Table
1. DNA extracts were amplified by a PCR
incorporating universal primers fD1 and rP2 (49)
(Eurogentec, Seraing, Belgium). PCR amplifications were performed in
100-µl volumes incorporating 10 µl of extracted DNA, 10 µl of
10× reaction buffer, 100 µM (each) deoxynucleoside triphosphate, 0.2 µM (each) primer, 2 U of Taq polymerase (Perkin-Elmer
Cetus, Norwalk, Conn.), and sterile, distilled water. Amplifications
were carried out in a Perkin-Elmer 9600 thermal cycler for 35 cycles,
with each cycle consisting of denaturation at 95°C for 30 s,
primer annealing at 55°C for 30 s, and extension at 72°C for
60 s. The success of the amplification was determined by ethidium
bromide staining following the resolution of products by 1% agarose
gel electrophoresis. Each experiment included sterile water (no DNA) as
a negative control and Escherichia coli DNA as a positive
control. The products of 16S rRNA gene amplification were purified for
sequencing by using Microspin S-400 HR columns (Pharmacia Biotech,
Uppsala, Sweden) according to the manufacturer's instructions.
Sequencing reactions were prepared by using the Amplicycle sequencing
kit (Perkin-Elmer), according to the manufacturer's instructions, and
one of six 5' fluorescein-labelled primers was incorporated into the
reaction mixture (Table 1). The thermal cycle used in each sequencing reaction was dependent on the base sequence of the primer (Table 1).
When the primer annealing temperature was
50°C, an initial denaturation step at 95°C for 1 min was followed by 25 cycles, with
each cycle comprising denaturation at 95°C for 30 s, annealing for 30 s, and extension at 72°C for 1 min. Amplification was
completed by an extension step of 5 min at 72°C to allow complete
extension of the amplified products. When the primer annealing
temperature was <50°C, an initial denaturation step at 95°C for 1 min was followed by 30 cycles, with each cycle comprising denaturation at 95°C for 30 s, annealing for 30 s, and extension at
60°C for 2 min. Ten supplementary cycles of denaturation at 95°C
for 10 s and extension at 60°C for 90 s were performed in
order to increase the amount of polymerization. Sequencing reactions
were carried out on a Perkin-Elmer 9600 thermal cycler, and reaction
products were resolved by electrophoresis on a 6% polyacrylamide gel
incorporated into an ALF Automatic Sequencer (Pharmacia Biotech).
Sequence analysis.
Partial 16S rRNA gene sequences derived
from each reaction mixture with the ALF manager were combined in a
complete sequence by using PC Gene software (IntelliGenetics Inc.). The
complete sequence was then compared with all bacterial sequences
available in the GenBank database, by using the multisequence
comparison program FASTA (part of the BISANCE software package)
(14).
 |
RESULTS |
Bacterium from patient 1.
The bacterium isolated from patient
1 was thought to be a strain of G. haemolysans on the basis
of conventional phenotypic identification. Growth was easily achieved
on Columbia agar with incubation at 37°C under 5% CO2,
but only poor growth was obtained under anaerobic conditions. Colonies
were small and weakly beta-hemolytic after 5 days of incubation.
Microscopic examination after Gram staining yielded gram-positive cocci
which became gram-variable after subculture. Cocci were arranged in
pairs, short chains, or clusters and were of various sizes. The results
of biochemical reactions and enzyme analyses are summarized in Table
2. Sequence data for 1,022 bp of the 16S
rRNA gene were obtained. After removing ambiguities, the sequence
demonstrated 99.9% similarity to the 16S rRNA gene sequence of
G. haemolysans (GenBank accession no. L14326)
(50).
Bacterium from patient 2.
The bacterium isolated from patient
2 was thought to be a strain of G. morbillorum on the basis
of conventional phenotypic identification. Growth was easily obtained
on Columbia agar with incubation at 37°C under 5% CO2
and under anaerobic conditions. Colonies were weakly alpha-hemolytic
only when they were incubated under 5% CO2. Microscopic
examination after Gram staining yielded gram-variable cocci and
coccobacilli arranged in pairs, short chains, or clusters and of
various sizes. The results of biochemical reactions and enzyme analyses
are summarized in Table 2. Sequence data for 948 bp of the 16S rRNA
gene were obtained. After removing ambiguities, the sequence
demonstrated 99.8% similarity to the 16S rRNA gene sequence of
G. morbillorum (GenBank accession no. L14327).
Bacterium from patient 3.
Conventional phenotypic
characterization of the gram-negative coccobacilli yielded no definite
identification. Visible growth was obtained after 3 or 4 days on
Columbia agar with incubation at 37°C under 5% CO2. The
colonies were small and nonhemolytic. Sequence data for 949 bp of the
16S rRNA gene were obtained. After removing ambiguities, the sequence
demonstrated 99.68% similarity to the 16S rRNA gene sequence of
G. morbillorum (GenBank accession no. L14327). Conventional
biochemical identification was reassessed. The results are summarized
in Table 2 and are compatible with the identification of the bacterium
as G. morbillorum with the exception of the results obtained
by Gram staining. Subsequently, a more complete 16S rRNA gene sequence
was determined. This 1,474-bp sequence demonstrated 99.73% similarity
with the 16S rRNA gene sequence of G. morbillorum.
Cellular fatty acids.
The major fatty acids in cells were
identified as C16 and C18, but definite
identification was not achieved by this technique.
Electron microscopy.
All bacteria studied presented with a
typical gram-positive membrane organization. Some cells appeared as
short bacilli, usually when they were in the process of dividing.
 |
DISCUSSION |
G. morbillorum was originally proposed as
Diplococcus rubeolae (47), and a second member of
the genus named Diplococcus morbillorum was added soon after
(41). However, on reappraisal the two Diplococcus
species were considered to be identical and were unified under the name
D. morbillorum. Although D. morbillorum could be
grown under aerobic conditions, it was primarily anaerobic, and on this
basis it was transferred to the genus Peptostreptococcus (44), only to be reclassified into the genus
Streptococcus (26). G. haemolysans was
first described in 1938 as Neisseria haemolysans (46) (demonstrating its indeterminate Gram staining
characteristic), but the species was reclassified into a new genus,
Gemella (7), following demonstration of
biochemical differences with other Neisseria species. The
nucleotide sequence of the 16S rRNA gene of Streptococcus
morbillorum was found to closely resemble that of G. haemolysans (32), and on the basis of DNA-DNA
hybridization results and G+C content analysis, it was proposed that
S. morbillorum be transferred to the genus
Gemella as G. morbillorum comb. nov. (30). The phylogenetic relationships of Gemella
spp. to other gram-positive bacteria are presented in Fig.
1.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Phylogenetic tree based on 16S rRNA gene sequences
available in the GenBank database obtained by the neighbor-joining
method. The phylogenetic relationships of G. haemolysans and
G. morbillorum with selected gram-positive bacteria with low
G+C contents are shown. The bar represents a 1% difference in
nucleotide sequence.
|
|
G. morbillorum and G. haemolysans are uncommon
causes of infectious endocarditis; a review of the literature reveals
only 10 cases caused by G. morbillorum (1, 6, 10, 12,
29, 33, 35, 40, 45) and 12 cases caused by G. haemolysans (8, 9, 11, 15, 22, 25, 28, 31, 34, 39, 43). Two additional cases of G. morbillorum endocarditis have
been recorded among 52 apparent failures of endocarditis prophylaxis (17), and 8 cases have been recorded among 364 cases of
streptococcal endocarditis (19). The patients described in
Table 3 and Table 4 demonstrate that poor dental state
and/or dentistry are predisposing factors, as in patients with
endocarditis caused by viridans group streptococci. Previous valvular
damage is also a common occurrence. In most cases, the infections were
successfully treated with antibiotic therapy, usually benzylpenicillin
or amoxicillin associated with gentamicin.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Summary of patients with reported cases of G. morbillorum endocarditis and features of our two patients with
G. morbillorum endocarditisa
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Summary of reported cases of G. haemolysans
endocarditis and features of our patient with G. haemolysans endocarditisa
|
|
Gemella spp. possess a typical gram-positive cell wall
structure, as confirmed by electron microscopy in this study. However during Gram staining, cells are easily decolorized and may therefore may appear to be gram variable and even gram negative. It is likely that Gram staining abnormality and morphological polymorphism are
responsible for the misidentification of Gemella spp. and, thus, perhaps for the fact that so few cases of Gemella
infection are reported. Rapid phenotypic identification systems are
unable to identify accurately all strains of these species (3,
20), even though manufacturers have significantly improved their
databases over recent years (e.g., the Rapid ID 32 Strep database
[21]).
Nevertheless, for two cases of infection described in this report,
identification of G. morbillorum or G. haemolysans as the causative agents was achieved by standard
phenotypic identification schemes. Identification of the organism
causing infection in patient 3 was difficult, however, even though a
large number of biochemical tests were performed. After its
identification had been achieved by the PCR-based approach with the 16S
rRNA gene and the bacterium had been recognized as being gram positive,
reassessment of phenotypic characteristics revealed a correct identity.
The same problem had already occurred with a short, "gram-negative"
bacillus, isolated from a patient with infectious arthritis, which had
been sent to our laboratory for identification; analysis of its 16S
rRNA gene also revealed that this isolate was G. morbillorum
(unpublished data).
In our laboratory, we now routinely use cell wall fatty acid analysis
and/or 16S rRNA gene analysis when a bacterium is not easily identified
by phenotypic schemes. About 0.05 to 0.1% of all isolates fall into
this category. Amplification with universal primers, partial sequencing
(about 900 bp) with conserved primers, and sequence comparison take
less than 3 days. If the partial 16S rRNA gene sequence obtained shares
more than 99% similarity with a specific 16S rRNA gene sequence in the
database, the bacterium may be considered to be identified, provided
that the genes of closely related species share a significantly lower
degree of similarity. However, if this is not the case, complete
identification can be achieved in two ways. First, confirmation can be
achieved by a few simple additional biochemical tests, as described for patient 3 of this study. This method is quick and cheap, but it requires that a bacterium be easily subcultured. If this is not possible, additional sequencing can be used in order to determine a
complete 16S rRNA gene sequence. This second approach is more expensive
and time-consuming, but it avoids the need for additional phenotypic or
specific antibody tests, both of which may not be routinely available
in the diagnostic laboratory and thus would require referral to a
reference laboratory. Furthermore, this approach also allows the
description of new pathogens (16) which may have been
misidentified by standard phenotypic identification schemes. Finally,
the use of this technique for identification does not require an
experienced microbiologist and gives a universal bacterial
identification ability to all laboratories, provided that they are
equipped with an automated sequencer. With increasing availability and
decreasing costs, such equipment is likely to become a feature of more
and more routine laboratories in the years to come.
However, for the present, phenotypic characterization remains the
standard approach to bacterial identification, with Gram staining being
one of the most important first steps of most routine identification
schemes (5). A mistake at this stage can lead to the
application of inappropriate tests and therefore unnecessary delays in
processing; thus, it is important that all efforts be made to ensure
correct interpretation of the Gram staining result. The reference
method for assessing cell wall type is electron microscopy, and
although it is accurate, the method is expensive, is time-consuming,
and requires specialized equipment. As an alternative we have added
vancomycin and colistin to our standard antibiotic susceptibility
tests. Most gram-positive bacteria are susceptible to vancomycin,
whereas most gram-negative bacteria are susceptible to colistin. Such a
method has previously been shown to be beneficial for the determination
of cell wall type among nonenterobacterial rods (24). The
test is easy to perform (Fig. 2) and is
inexpensive. It must be noted, however, that this test is not
definitive, since a vancomycin-resistant strain of G. haemolysans has been encountered (18).

View larger version (96K):
[in this window]
[in a new window]
|
FIG. 2.
Examples of the usefulness of vancomycin test to
determine the Gram reaction for gram-variable bacteria. The
vancomycin-susceptible gram-positive bacterium is G. haemolysans (A), and the vancomycin-resistant gram-negative
bacteria are Acinetobacter (B), Moraxella sp.
(C), and Kingella kingae (D). Arrowheads indicate the limits
of the inhibition zone around vancomycin (VA) and colistin (CS)
disks.
|
|
In conclusion, for bacteria which are easily identified by phenotypic
schemes (especially with the help of commercial identification kits or
simple additional tests) and which represent more than 99.9% of the
bacteria isolated in clinical microbiology laboratories, no additional
identification technique is required. However, 16S rRNA gene analysis
is becoming more competitive in terms of efficiency and accuracy for
fastidious bacteria or those not easily identified by phenotypic
schemes. The use of 16S rRNA gene analysis should also lead to an
increase in the number of descriptions of new pathogens and in the
recovery of unexpected pathogens.
 |
ACKNOWLEDGMENT |
We thank Richard Birtles for correcting the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unité des
Rickettsies, CNRS UPRESA 6020, Faculté de Médecine,
Université de la Mediterrannée, 27 Blvd. Jean Moulin, 13385 Marseille Cedex 05, France. Phone: (33).4.91.38.55.17. Fax:
(33).4.91.83.03.90. E-mail: Didier.Raoult{at}medecine.univ-mrs.fr.
 |
REFERENCES |
| 1.
|
Abboud, R., and A. Friart.
1995.
Deux cas d'endocardite tricuspidienne isolée après intervention colique.
Acta Clin. Belg.
50:242-245[Medline].
|
| 2.
|
Acar, J. F., and F. W. Goldstein.
1996.
Disk susceptibility test, p. 1-51.
In
V. Lorian (ed.), Antibiotics in laboratory medecine, 4th ed. The Williams & Wilkins Co., Baltimore, Md.
|
| 3.
|
Appelbaum, P. C.,
M. R. Jacobs,
J. L. Heald,
W. M. Palko,
A. Duffett,
R. Crist, and P. A. Naugle.
1984.
Comparative evaluation of the API 20S system and the AutoMicrobic System Gram-Positive Identification Card for species identification of streptococci.
J. Clin. Microbiol.
19:164-168[Abstract/Free Full Text].
|
| 4.
|
Aspevall, O.,
E. Hillebrandt,
B. Linderoth, and M. Rylander.
1991.
Meningitis due to Gemella haemolysans after neurosurgical treatment of trigeminal neuralgia.
Scand. J. Infect. Dis.
23:503-505[Medline].
|
| 5.
|
Baron, E. J.,
A. S. Weissfeld,
P. A. Fuselier, and D. J. Brenner.
1995.
Classification and identification of bacteria, p. 249-264.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
|
| 6.
|
Bell, E., and A. C. McCartney.
1992.
Gemella morbillorum in an intravenous drug abuser.
J. Infect.
25:110-112[Medline].
|
| 7.
|
Berger, U.
1961.
A proposed new genus of gram negative cocci: Gemella.
Int. Bull. Bacteriol. Nomencl. Taxon.
11:17-19.
|
| 8.
|
Brack, M. J.,
P. G. Avery,
P. J. B. Hubner, and R. A. Swann.
1991.
Gemella haemolysans: a rare and unusual cause of infective endocarditis.
Postgrad. Med. J.
67:210-212.
|
| 9.
|
Buu-Hoi, A.,
A. Sapoetra,
C. Branger, and J. F. Acar.
1982.
Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis.
Eur. J. Clin. Microbiol.
1:102-106[Medline].
|
| 10.
|
Calopa, M.,
F. Rubio,
M. Aguilar, and J. Peres.
1990.
Giant basilar aneurysm in the course of subacute bacterial endocarditis.
Stroke
21:1625-1627[Abstract/Free Full Text].
|
| 11.
|
Chatelain, R.,
J. Croize,
P. Rouge,
C. Massot,
H. Dabernat,
J. C. Auvergnat,
A. Buu-Hoi,
J. P. Stahl, and F. Bimet.
1982.
Isolement de Gemella haemolysans dans trois cas d'endocardites bactériennes.
Med. Mal. Infect.
1:25-30.
|
| 12.
|
Coto, U., and S. L. Berk.
1984.
Endocarditis caused by Streptococcus morbillorum.
Am. J. Med. Sci.
287:54-57[Medline].
|
| 13.
|
Debast, S. B.,
R. Koot, and J. F. Meis.
1993.
Infections caused by Gemella morbillorum.
Lancet
342:560[Medline].
|
| 14.
|
Dessen, P.,
C. Frondat,
C. Valencien, and G. Munier.
1990.
BISANCE: a French service for access to biomolecular sequences databases.
Comput. Appl. Biosci.
6:355-356[Free Full Text].
|
| 15.
|
Devuyst, O.,
P. Hainaut,
J. Gigi, and G. Wauters.
1993.
Rarity and potential severity of Gemella haemolysans endocarditis.
Acta Clin. Belg.
48:52-53[Medline].
|
| 16.
|
Drancourt, M.,
L. Niel, and D. Raoult.
1995.
Unknown multiresistant gram negative bacterium causing meningitis in HIV-positive patient in Africa.
Lancet
346:1168[Medline].
|
| 17.
|
Durack, D. T.,
E. L. Kaplan, and A. L. Bisno.
1983.
Apparent failures of endocarditis prophylaxis.
JAMA
250:2318-2322[Abstract/Free Full Text].
|
| 18.
|
Efstratiou, A.,
D. Morrisson, and N. Woodford.
1993.
Glycopeptide-resistant Gemella haemolysans from blood.
Lancet
342:927-928[Medline].
|
| 19.
|
Facklam, R. R.
1977.
Physiological differentiation of viridans streptococci.
J. Clin. Microbiol.
19:184-201.
|
| 20.
|
Facklam, R. R.,
D. L. Rhoden, and P. B. Smith.
1984.
Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species.
J. Clin. Microbiol.
20:894-898[Abstract/Free Full Text].
|
| 21.
|
Freney, J.,
S. Bland,
J. Etienne,
M. Desmonceaux,
J. M. Boeufgras, and J. Fleurette.
1992.
Description and evaluation of the semiautomated 4-hour Rapid ID 32 Strep method for identification of streptococci and members of related genera.
J. Clin. Microbiol.
30:2657-2661[Abstract/Free Full Text].
|
| 22.
|
Fresard, A.,
V. P. Michel,
X. Rueda,
G. Aubert,
G. Dorche, and F. Lucht.
1993.
Gemella haemolysans endocarditis.
Clin. Infect. Dis.
16:586-587[Medline].
|
| 23.
|
Garavelli, P. L.
1990.
Meningite da Streptococcus morbillorum.
Minerva Med.
81:69[Medline].
|
| 24.
|
Graevenitz, A., and C. Bucher.
1983.
Accuracy of the KOH and vancomycin tests in determining the Gram reaction of nonenterobacterial rods.
J. Clin. Microbiol.
18:983-985[Abstract/Free Full Text].
|
| 25.
|
Helft, G.,
X. Tabone,
J. P. Metzger, and A. Vacheron.
1993.
Gemella haemolysans endocarditis with colonic carcinoma.
Eur. J. Med.
2:369-370[Medline].
|
| 26.
|
Holdeman, L. V., and W. E. C. Moore.
1974.
New genus Coprococcus, twelve new species, and emended description of four previously described species from human feces.
Int. J. Syst. Bacteriol.
24:260-277[Abstract/Free Full Text].
|
| 27.
|
Joblet, C.,
V. Roux,
M. Drancourt,
J. Gouvernet, and D. Raoult.
1995.
Identification of Bartonella (Rochalimea) species among fastidious gram-negative bacteria on the basis of partial sequence of the citrate-synthase gene.
J. Clin. Microbiol.
33:1879-1883[Abstract].
|
| 28.
|
Kaufhold, A.,
D. Franzen, and R. Lütticken.
1989.
Endocarditis caused by Gemella haemolysans.
Infection
17:385-387[Medline].
|
| 29.
|
Kerr, J. R.,
C. H. Webb,
J. G. McGimpsey, and N. P. S. Campbell.
1994.
Infective endocarditis due to Gemella morbillorum complicating hypertrophic obstructive cardiomyopathy.
Ulster Med. J.
63:108-110[Medline].
|
| 30.
|
Kilpper-Bälz, R., and K. H. Schleifer.
1988.
Transfer of Streptococcus morbillorum to the genus Gemella as Gemella morbillorum, comb. nov.
Int. J. Syst. Bacteriol.
38:442-443[Abstract/Free Full Text].
|
| 31.
|
Laudat, P.,
P. Cosnay,
B. Icole,
A. Raoult,
P. Raynaud, and M. Brochier.
1984.
Endocardite à Gemella haemolysans: une nouvelle observation.
Med. Mal. Infect.
4:159-161.
|
| 32.
|
Ludwig, W.,
M. Weizenegger,
R. Kilpper-Bälz, and K. H. Schleifer.
1988.
Phylogenetic relationships of anaerobic streptococci.
Int. J. Syst. Bacteriol.
38:15-18[Abstract/Free Full Text].
|
| 33.
|
Martin, M. J.,
D. A. Wright, and A. R. R. Jones.
1995.
A case of Gemella morbillorum endocarditis.
Postgrad. Med. J.
71:188.
|
| 34.
|
Matsis, P. P., and R. N. Easthorpe.
1994.
Gemella haemolysans endocarditis.
Aust. N. Z. J. Med.
24:417-418[Medline].
|
| 35.
|
Maxwell, S.
1989.
Endocarditis due to Streptococcus morbillorum.
J. Infect.
18:67-72[Medline].
|
| 36.
|
May, T.,
C. Amiel,
C. Lion,
M. Weber,
A. Gerard, and P. Canton.
1993.
Meningitis due to Gemella haemolysans.
Eur. J. Clin. Microbiol. Infect. Dis.
12:644-645[Medline].
|
| 37.
|
Miller, L., and T. Berger.
1985.
Bacterial identification by gas chromatography of whole cell fatty acids. Hewlett-Packard application note 228-241.
Hewlett-Packard, Avondale, Pa.
|
| 38.
|
Mitchell, R. G., and P. J. Teddy.
1985.
Meningitis due to Gemella haemolysans after radiofrequency trigeminal rhizotomy.
J. Clin. Pathol.
38:558-560[Abstract/Free Full Text].
|
| 39.
|
Morea, P.,
M. Toni,
M. Bressan, and P. Stritoni.
1991.
Prosthetic valve endocarditis by Gemella haemolysans.
Infection
19:446[Medline].
|
| 40.
|
Omran, Y., and C. A. Wood.
1993.
Endovascular infection and septic arthritis caused by Gemella morbillorum.
Diagn. Microbiol. Infect. Dis.
16:131-134[Medline].
|
| 41.
|
Prevot, A. R.
1933.
Etudes de sytématique bactérienne. I. Lois générals. II. Cocci anaérobies.
Ann. Sci. Nat.
15:23-260.
|
| 42.
|
Ruoff, K. L.
1990.
Gemellae: a tale of two new species (and five genera).
Clin. Microbiol. Newsl.
12:1-4.
|
| 43.
|
Samuel, L., and P. Bloomfield.
1995.
Gemella haemolysans prosthetic valve endocarditis.
Postgrad. Med. J.
71:188.
|
| 44.
|
Smith, L.
1957.
Peptostreptococcus Kluyver and van Niel (1936), p. 533-541.
In
R. S. Breed, E. G. D. Murray, and N. R. Smith (ed.), Bergey's manual of determinative bacteriology, 7th ed. The Williams & Wilkins Co., Baltimore, Md.
|
| 45.
|
Terada, H.,
K. Miyahara,
H. Sohara,
M. Sonoda,
H. Venomachi,
J. Sanada, and T. Arima.
1994.
Infective endocarditis caused by an indigenous bacterium (Gemella morbillorum).
Intern. Med.
33:628-631[Medline].
|
| 46.
|
Thjöta, T., and J. Böe.
1938.
Neisseria haemolysans. A haemolytic species of Neisseria Treviscan.
Acta Pathol. Microbiol. Scand. Suppl.
37:527-531.
|
| 47.
|
Tunnicliff, R.
1917.
The cultivation of a micrococcus from blood in pre-eruptive and eruptive stage of measles.
JAMA
68:1028-1030.
|
| 48.
|
Von Essen, R.,
M. Ikävalko, and B. Forsblom.
1993.
Isolation of Gemella morbillorum from joint fluid.
Lancet
342:177-178[Medline].
|
| 49.
|
Weisburg, W. G.,
S. M. Barns,
D. A. Pelletier, and D. J. Lane.
1991.
16S ribosomal DNA amplification for phylogenic study.
J. Bacteriol.
173:697-703[Abstract/Free Full Text].
|
| 50.
|
Whitney, A. M., and S. P. O'Connor.
1993.
Phylogenetic relationship of Gemella morbillorum to Gemella haemolysans.
Int. J. Syst. Bacteriol.
43:832-838[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, April 1998, p. 866-871, Vol. 36, No. 4
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Johnson, R., Ramos-Vara, J., Vemulapalli, R.
(2009). Identification of Bartonella henselae in an Aborted Equine Fetus. Vet Pathol
46: 277-281
[Abstract]
[Full Text]
-
Anil, M., Ozkalay, N., Helvaci, M., Agus, N., Guler, O., Dikerler, A., Kanar, B.
(2007). Meningitis Due to Gemella haemolysans in a Pediatric Case. J. Clin. Microbiol.
45: 2337-2339
[Abstract]
[Full Text]
-
Zolezzi, P. C., Cepero, P. G., Ruiz, J., Laplana, L. M., Calvo, C. R., Gomez-Lus, R.
(2007). Molecular Epidemiology of Macrolide and Tetracycline Resistances in Commensal Gemella sp. Isolates. Antimicrob. Agents Chemother.
51: 1487-1490
[Abstract]
[Full Text]
-
Azap, O. K., Yapar, G., Timurkaynak, F., Arslan, H., Sezer, S., Ozdemir, N.
(2005). Gemella morbillorum peritonitis in a patient being treated with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant
20: 853-854
[Full Text]
-
Zakir, R. M., Al-Dehneh, A., Dabu, L., Kapila, R., Saric, M.
(2004). Mitral Bioprosthetic Valve Endocarditis Caused by an Unusual Microorganism, Gemella morbillorum, in an Intravenous Drug User. J. Clin. Microbiol.
42: 4893-4896
[Abstract]
[Full Text]
-
Elsayed, S., Zhang, K.
(2004). Gemella bergeriae Endocarditis Diagnosed by Sequencing of rRNA Genes in Heart Valve Tissue. J. Clin. Microbiol.
42: 4897-4900
[Abstract]
[Full Text]
-
Cerda Zolezzi, P., Laplana, L. M., Calvo, C. R., Cepero, P. G., Erazo, M. C., Gomez-Lus, R.
(2004). Molecular Basis of Resistance to Macrolides and Other Antibiotics in Commensal Viridans Group Streptococci and Gemella spp. and Transfer of Resistance Genes to Streptococcus pneumoniae. Antimicrob. Agents Chemother.
48: 3462-3467
[Abstract]
[Full Text]
-
Woo, P C Y, Lau, S K P, Fung, A M Y, Chiu, S K, Yung, R W H, Yuen, K Y
(2003). Gemella bacteraemia characterised by 16S ribosomal RNA gene sequencing. J. Clin. Pathol.
56: 690-693
[Abstract]
[Full Text]
-
Paster, B. J., Falkler, W. A. Jr., Enwonwu, C. O., Idigbe, E. O., Savage, K. O., Levanos, V. A., Tamer, M. A., Ericson, R. L., Lau, C. N., Dewhirst, F. E.
(2002). Prevalent Bacterial Species and Novel Phylotypes in Advanced Noma Lesions. J. Clin. Microbiol.
40: 2187-2191
[Abstract]
[Full Text]
-
Brouqui, P., Raoult, D.
(2001). Endocarditis Due to Rare and Fastidious Bacteria. Clin. Microbiol. Rev.
14: 177-207
[Abstract]
[Full Text]
-
La Scola, B., Raoult, D.
(1999). Third Human Isolate of a Desulfovibrio sp. Identical to the Provisionally Named Desulfovibrio fairfieldensis. J. Clin. Microbiol.
37: 3076-3077
[Abstract]
[Full Text]